Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Abbott
>
Abbott Laboratories reports Q4 results
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 6175283"]Worldwide sales increased 2.3% to of $7.77 billion. The results were benefited by the higher sales from Medical Devices and Diagnostics businesses.</p><p><br /></p><p>Sales from Medical Devices grew 6.7% year-over-year. In Electrophysiology, the 16.7% growth was led by strong performance in cardiac mapping and ablation catheters. The 12.4% growth in Structural Heart was driven by several product areas across Abbott’s broad portfolio. In Diabetes Care, sales jumped 28.3%, led by rapid market uptake of FreeStyle Libre, which removes the need for routine fingersticks for people with diabetes.</p><p><br /></p><p>Source: <a href="https://news.alphastreet.com/abbott-laboratories-q4-2018-earnings-results-abt-stock/" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://news.alphastreet.com/abbott-laboratories-q4-2018-earnings-results-abt-stock/" rel="nofollow">https://news.alphastreet.com/abbott-laboratories-q4-2018-earnings-results-abt-stock/</a>[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 6175283"]Worldwide sales increased 2.3% to of $7.77 billion. The results were benefited by the higher sales from Medical Devices and Diagnostics businesses. Sales from Medical Devices grew 6.7% year-over-year. In Electrophysiology, the 16.7% growth was led by strong performance in cardiac mapping and ablation catheters. The 12.4% growth in Structural Heart was driven by several product areas across Abbott’s broad portfolio. In Diabetes Care, sales jumped 28.3%, led by rapid market uptake of FreeStyle Libre, which removes the need for routine fingersticks for people with diabetes. Source: [URL]https://news.alphastreet.com/abbott-laboratories-q4-2018-earnings-results-abt-stock/[/URL][/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Abbott
>
Abbott Laboratories reports Q4 results
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Abbott
>
Abbott Laboratories reports Q4 results
>